There are currently two approved drugs to treat ALS: riluzole, which can extend lifespan by an average of a few months and has been on the market for 25 年, and the 2017-approved edaravone, which was shown in clinical trials to help patients function for longer into their disease
干细胞介导的衰老组织再生: 细胞和分子视角
干细胞介导的衰老组织再生: 细胞和分子视角 摘要 几乎所有组织的衰老都伴随着逐渐的功能衰退. 现代再生生物学研究基于干细胞的策略是否可以恢复结构完整性和生理性能 阅读更多